With 20 years of experience in the software industry, I’ve built my career at the intersection of technology, strategy, and innovation—leading high-impact projects from concept to deployment across sectors like AI, data analytics, and now genomics. I specialize in helping organizations harness the power of data to drive strategic decisions, unlock automation opportunities, and create lasting competitive advantages. My leadership style is hands-on and integrative: I lead multidisciplinary teams, manage full project lifecycles, and translate complex technical goals into executable strategies that scale. As the founder of Aspen AI, I advise companies on how to adopt AI responsibly and effectively. My focus spans business-aligned automation, governance, data architecture, and scalable solution design. I’ve led projects involving agent-based systems, predictive analytics, and intelligent automation—always grounded in business impact. More recently, I co-founded Dot1.bio, a biotech startup where we decode the 0.1% of human DNA that varies between individuals to generate actionable insights in health, nutrition, and mental performance. By combining genomic sequencing with advanced data science, we’re creating tools that bring precision medicine closer to everyday wellness, with a strong focus on the gut-brain axis. What sets me apart is the ability to operate across domains with a strategic mindset and deep technical fluency. I don’t just execute; I align innovation with purpose, ensuring every project delivers measurable value. I’m committed to driving the future of data-driven transformation, guiding both companies and emerging ventures through the complex but rewarding path of AI and biotech innovation.